AC
Armistice Capital Portfolio holdings
AUM
$2.64B
This Quarter Return
-5.45%
1 Year Return
+0.99%
3 Year Return
+16.29%
5 Year Return
+18.04%
10 Year Return
+34.8%
AUM
$3.74B
AUM Growth
+$3.74B
(-13%)
Cap. Flow
-$167M
Cap. Flow
% of AUM
-4.47%
Top 10 Holdings %
Top 10 Hldgs %
31.26%
Holding
292
New
63
Increased
73
Reduced
62
Closed
70
Top Buys
| 1 |
Freshpet
FRPT
|
$59.6M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
$54.6M |
| 3 |
Keurig Dr Pepper
KDP
|
$37.6M |
| 4 |
STAAR Surgical
STAA
|
$37.5M |
| 5 |
Smith & Nephew
SNN
|
$36.2M |
Top Sells
| 1 |
Vertex Pharmaceuticals
VRTX
|
$84.4M |
| 2 |
NARI
Inari Medical, Inc. Common Stock
NARI
|
$79.9M |
| 3 |
GSK
GSK
|
$77.5M |
| 4 |
AB InBev
BUD
|
$68M |
| 5 |
Humana
HUM
|
$67.7M |
Sector Composition
| 1 | Healthcare | 63.24% |
| 2 | Consumer Discretionary | 12.22% |
| 3 | Consumer Staples | 9.75% |
| 4 | Technology | 9.6% |
| 5 | Communication Services | 2.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
PTC Therapeutics
PTCT
$3.92B
| $277M | 4.15% | 5,434,843 -943,157 | -15% | -$48.1M |
|
2
Supernus Pharmaceuticals
SUPN
$2.53B
| $170M | 2.55% | 5,196,000 +360,000 | +7% | +$11.8M |
|
3
Travere Therapeutics
TVTX
$1.56B
| $159M | 2.38% | 8,872,000 +1,514,000 | +21% | +$27.1M |
|
4
Neurocrine Biosciences
NBIX
$13.8B
| $111M | 1.66% | 1,000,190 +108,190 | +12% | +$12M |
|
5
Incyte
INCY
$16.5B
| $101M | 1.52% | 1,671,463 -96,367 | -5% | -$5.84M |
|
6
Immunovant
IMVT
$2.56B
| $76.9M | 1.15% | 4,500,000 +629,414 | +16% | +$10.8M |
|
7
Exact Sciences
EXAS
$8.98B
| $76.7M | 1.15% | 1,772,369 +155,369 | +10% | +$6.73M |
|
|
8
Regeneron Pharmaceuticals
REGN
$61.5B
| $72.3M | 1.08% | 114,073 +86,028 | +307% | +$54.6M |
|
9
Grifois
GRFS
$6.78B
| $66M | 0.99% | 9,278,000 -758,000 | -8% | -$5.39M |
|
10
Agios Pharmaceuticals
AGIO
$2.19B
| $60M | 0.9% | 2,048,000 -216,304 | -10% | -$6.34M |
|
|
11
Freshpet
FRPT
$2.72B
| $59.6M | 0.89% | +716,960 | New | +$59.6M |
|
12
argenx
ARGX
$43.6B
| $58M | 0.87% | 98,000 -26,000 | -21% | -$15.4M |
|
13
FIVE9
FIVN
$2.08B
| $57M | 0.85% | 2,098,000 +127,793 | +6% | +$3.47M |
|
|
14
STAAR Surgical
STAA
$1.36B
| $52.9M | 0.79% | 3,000,000 +2,128,000 | +244% | +$37.5M |
|
15
Treace Medical Concepts
TMCI
$464M
| $52.1M | 0.78% | 6,211,000 +2,000 | +0% | +$16.8K |
|
16
PENN Entertainment
PENN
$2.95B
| $50.3M | 0.75% | 3,086,057 -212,211 | -6% | -$3.46M |
|
17
Boston Beer
SAM
$2.41B
| $50.3M | 0.75% | 210,553 +88,624 | +73% | +$21.2M |
|
18
Amazon
AMZN
$2.44T
| $50.3M | 0.75% | 264,126 +79,024 | +43% | +$15M |
|
|
19
Smith & Nephew
SNN
$16.3B
| $50.2M | 0.75% | 1,769,000 +1,275,000 | +258% | +$36.2M |
|
20
Microsoft
MSFT
$3.77T
| $49.6M | 0.74% | 132,000 +36,034 | +38% | +$13.5M |
|
21
Spectrum Brands
SPB
$1.38B
| $49.4M | 0.74% | 691,000 +115,143 | +20% | +$8.24M |
|
22
Medtronic
MDT
$119B
| $48.6M | 0.73% | 541,237 -208,927 | -28% | -$18.8M |
|
23
Orthofix Medical
OFIX
$592M
| $48.3M | 0.72% | 2,964,000 -36,000 | -1% | -$587K |
|
24
Simply Good Foods
SMPL
$2.88B
| $46.6M | 0.7% | 1,351,593 +166,319 | +14% | +$5.74M |
|
25
Alphabet (Google) Class A
GOOGL
$2.57T
| $45.9M | 0.69% | 297,000 +85,112 | +40% | +$13.2M |
|